A Phase II Study of Low-Intensity Chemotherapy (Mini-Hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
暂无分享,去创建一个
H. Kantarjian | F. Ravandi | E. Jabbour | N. Daver | N. Pemmaraju | N. Jain | N. Short | C. Loiselle | L. Masarová | G. Issa | M. Yilmaz | W. Jen | L. Nasr | F. Haddad | M. Zoghbi | G. Banks | Wu Deen | Lourdes Waller | Rebecca E. Garris | Cedric Nasnas